Keyhole Limpet Hemocyanin-derived peptides presented on Major Histocompatibility Complex Class II (KLH-MHC II)

Keyhole Limpet Hemocyanin (KLH) is a high-molecular-weight, copper-containing respiratory protein derived from the marine mollusk Megathura crenulata (Harris & Markl, 1999). When introduced into the human body, KLH is recognized as a foreign neoantigen and is rapidly internalized by professional antigen-presenting cells, specifically dendritic cells. Within these cells, KLH undergoes proteolytic processing in the endosomal compartment, resulting in the generation of various peptides that are subsequently loaded onto Major Histocompatibility Complex Class II (MHC II) molecules for surface display (Swaminathan et al., 2014). This KLH-peptide-MHC II complex is the fundamental unit recognized by the T-cell receptors (TCR) of naive CD4+ T helper cells, serving as the primary stimulus for the initiation of an adaptive immune response. In clinical practice, the presentation of KLH peptides on MHC II is utilized as a robust diagnostic tool to assess the functional status of a patient's cellular and humoral immune systems, particularly in the context of immunotoxicity testing for new drug candidates (Lebrec et al., 2014). Furthermore, KLH serves as a critical carrier protein in the development of conjugate vaccines, where it provides the necessary T-cell epitopes to drive a strong immune response against otherwise weakly immunogenic haptens or tumor-associated antigens (Ragupathi et al., 2003). Drugs that interact with this target system include KLH itself, which acts as the precursor antigen, and various immunosuppressants like cyclosporine or corticosteroids that modulate the downstream T-cell response to the complex. The complex is also a key component in the manufacturing of autologous dendritic cell vaccines, where DCs are pulsed with KLH to act as an adjuvant or a tracer for immune monitoring.

Other names

KLH-MHC II complexMHC II-presented KLH peptidesKeyhole Limpet Hemocyanin antigen complexKLH-peptide-MHC class IIKLH-derived peptides presented on MHC II of dendritic cells

The complex acts as a specific antigenic ligand that binds to the T-cell receptor (TCR) on CD4+ T cells, initiating the primary signal for T-cell activation and the subsequent adaptive immune cascade (Swaminathan et al., 2014).